Q32 Bio Inc faces significant risks in maintaining proper and effective internal controls as required by Nasdaq and the Sarbanes-Oxley Act. The company must enhance its accounting and finance ...
insurance acceptance and Sarbanes-Oxley readiness, acquisition costs, severance expenses and stock-based compensation expense. We have provided below a reconciliation of adjusted EBITDA to net loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback